drugset / Trial / NCT05458024
Vitamin D to ENhance TraUma REcovery
Phase 2
Completed
71 enrolled
University of North Carolina, Chapel Hill
National Institute on Minority Health and Health Disparities (NIMHD) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The main objective of this study is to determine whether the administration of a single dose of Vitamin D in the Emergency Department following a motor vehicle collision can improve musculoskeletal pain severity as well as reduce musculoskeletal pain outcome disparity between Blacks and White following a motor vehicle collision. This randomized controlled trial is a pilot study to determine feasibility and potential efficacy (response to study drug, ability to reduce racial disparity in pain outcomes). This data can be used to adequately power a larger randomized controlled trial to fully assess efficacy.
Timeline
- Start
- 2023-01-24
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ergocalciferol | Small molecule | 300000 iu | — |